biote Corp.

NasdaqGM:BTMD Stock Report

Market Cap: US$204.9m

biote Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Terry Weber

Chief executive officer

US$3.8m

Total compensation

CEO salary percentage15.7%
CEO tenure5.8yrs
CEO ownershipn/a
Management average tenure2.7yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Dec 02
biote Corp. (NASDAQ:BTMD) Soars 26% But It's A Story Of Risk Vs Reward

Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

Sep 27
Market Cool On biote Corp.'s (NASDAQ:BTMD) Revenues

biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upside

Sep 27

Biote partners with IMAC Holdings

Sep 07

CEO Compensation Analysis

How has Terry Weber's remuneration changed compared to biote's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$7m

Jun 30 2024n/an/a

US$4m

Mar 31 2024n/an/a

US$8m

Dec 31 2023US$4mUS$601k

US$3m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$8m

Dec 31 2022US$7mUS$541k

-US$969k

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

US$11m

Mar 31 2022n/an/a

US$24m

Dec 31 2021US$1mUS$1m

US$33m

Compensation vs Market: Terry's total compensation ($USD3.82M) is above average for companies of similar size in the US market ($USD1.42M).

Compensation vs Earnings: Terry's compensation has been consistent with company performance over the past year.

CEO

Terry Weber (71 yo)

5.8yrs

Tenure

US$3,816,739

Compensation

Ms. Teresa S. Weber, also known as Terry, serves as Chief Executive Officer of biote Corp. (formerly BioTe Holdings, LLC) since March 2019 and its Director since June 2018. Prior to joining Biote, Ms. Webe...

Leadership Team

NamePositionTenureCompensationOwnership
Marc Beer
Executive Chairman4yrsUS$1.65mno data
Teresa Weber
CEO & Director5.8yrsUS$3.82mno data
Mary Conlon
VP of Business Development3.6yrsUS$1.05m0.45%
$ 924.7k
Robert Peterson
Chief Financial Officer1yrno datano data
John Olsen
Chief Information Officerless than a yearno datano data
James Gibbs
Chief People Officer1.1yrsno datano data
Richard Key
Chief Digital Officer4yrsno datano data
Jade Beutler
Head of Nutraceuticals2.7yrsno datano data
Cory Rice
Chief Clinical Advisor & Member of Medical Advisory Boardno datano datano data

2.7yrs

Average Tenure

59yo

Average Age

Experienced Management: BTMD's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Marc Beer
Executive Chairman4yrsUS$1.65mno data
Teresa Weber
CEO & Director6.6yrsUS$3.82mno data
Cory Rice
Chief Clinical Advisor & Member of Medical Advisory Boardno datano datano data
Steven Heyer
Independent Director2.7yrsUS$254.00k3.41%
$ 7.0m
Andrew Heyer
Independent Director2.7yrsUS$239.01k7.49%
$ 15.4m
Debra Morris
Independent Director2.2yrsUS$143.39k0.13%
$ 257.6k
Mickey Karram
Chair of Medical Advisory Boardno datano datano data
S. Cone
Independent Director3.4yrsUS$224.52k0.46%
$ 940.7k
Dana Jacoby
Independent Director2.7yrsUS$236.56k0.16%
$ 335.7k
Bruce Dorr
Senior Medical Advisor & Member of Medical Advisory Boardno datano datano data
Lisa Jukes
Member of Medical Advisory Boardno datano datano data
Peter Castillo
Member of Medical Advisory Boardno datano datano data

2.7yrs

Average Tenure

65yo

Average Age

Experienced Board: BTMD's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 21:04
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

biote Corp. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey Van SinderenB. Riley Securities, Inc.
Alex FuhrmanCraig-Hallum Capital Group LLC
Kaumil GajrawalaJefferies LLC